Oncopeptides Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 4,613,076 | 2.1% |
VC/PE Firms | 27,296,255 | 12.4% |
Institutions | 36,119,584 | 16.5% |
General Public | 151,317,781 | 69% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 132.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
27,296,255 | US$6.9m | 66.4% | 2.42% | |||
13,936,083 | US$3.5m | 367% | 0.09% | |||
8,286,806 | US$2.1m | 0% | 5.15% | |||
7,319,861 | US$1.9m | 0% | 0.07% | |||
2,268,252 | US$575.4k | 0% | no data | |||
2,105,589 | US$534.2k | 0% | no data | |||
1,780,262 | US$451.6k | 0% | no data | |||
1,039,239 | US$263.6k | 0% | no data | |||
868,331 | US$220.3k | 0% | no data | |||
668,728 | US$169.6k | 0% | no data | |||
569,322 | US$144.4k | 0% | 0.25% | |||
415,695 | US$105.5k | 0% | 0.19% | |||
415,695 | US$105.5k | 0% | no data | |||
389,385 | US$98.8k | 0% | no data | |||
388,585 | US$98.6k | 0% | no data | |||
352,437 | US$89.4k | 0% | 0.02% | |||
325,327 | US$82.5k | 0% | no data | |||
307,253 | US$77.9k | 0% | no data | |||
289,179 | US$73.4k | 0% | no data | |||
225,788 | US$57.3k | 0% | no data | |||
220,458 | US$55.9k | 0% | 0.02% | |||
120,200 | US$30.5k | 0% | no data | |||
100,000 | US$25.4k | 0% | no data | |||
57,750 | US$14.7k | 0% | no data | |||
53,800 | US$13.6k | 0% | no data |